SeaStar Medical Holding Corp Financial Ratios
ICU|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score -9.99 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-116.7%
Profit Margin
-984.6%
Net Income / Revenue
Asset Turnover
0.09
Revenue / Total Assets
Equity Multiplier
1.36
Total Assets / Equity
Composite: -116.6% (reported: -116.7%)
Profitability
Liquidity
Current Ratio
3.63
Quick Ratio
3.61
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.09
Inventory Turnover
0.80
Days Sales Outstanding
70 days
As of FY2025 · SEC 10-K · Updated Jun 29, 2026
Earnings Quality
Accrual Ratio
+15.4%
+204.8pp YoY
Earnings include a notable portion of accrual components.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.